Lei Shi

8PUBLICATIONS
116CO-AUTHORS
Cancer cell biologyCancer diagnosisMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 09, 2026
Inflammatory cytokines induce new cancer dependencies.

|May 12, 2025
Generation of a Biliary Tract Cancer Cell Line Atlas Identifies Molecular Subtypes and Therapeutic Targets.

Vindhya Vijay, Negin Karisani, Lei Shi

|Jul 11, 2024
Mutant IDH1 inhibition induces dsDNA sensing to activate tumor immunity.

Meng-Ju Wu, Hiroshi Kondo, Ashwin V Kammula

|Jan 23, 2024
Reprogramming the Intrahepatic Cholangiocarcinoma Immune Microenvironment by Chemotherapy and CTLA-4 Blockade Enhances Anti-PD-1 Therapy.

Jiang Chen, Zohreh Amoozgar, Xin Liu

|Mar 14, 2023
SULT1A1-dependent sulfonation of alkylators is a lineage-dependent vulnerability of liver cancers.

Lei Shi, William Shen, Mindy I Davis

|Apr 14, 2022
EGFR Inhibition Potentiates FGFR Inhibitor Therapy and Overcomes Resistance in FGFR2 Fusion-Positive Cholangiocarcinoma.

Qibiao Wu, Yuanli Zhen, Lei Shi

Pageof 2

Frequent Collaborators

7 joint publications

Meng-Ju Wu

4 joint publications

Nabeel Bardeesy

3 joint publications

Vindhya Vijay

3 joint publications

Kira Olander